Teamwork Financial Advisors LLC Trims Stake in CVS Health Co. (NYSE:CVS)

Teamwork Financial Advisors LLC trimmed its position in shares of CVS Health Co. (NYSE:CVS) by 3.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,419 shares of the pharmacy operator’s stock after selling 331 shares during the period. Teamwork Financial Advisors LLC’s holdings in CVS Health were worth $831,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new position in CVS Health in the 4th quarter valued at $1,092,040,000. Capital International Investors lifted its holdings in CVS Health by 47.4% during the 4th quarter. Capital International Investors now owns 33,691,698 shares of the pharmacy operator’s stock valued at $2,660,298,000 after buying an additional 10,837,801 shares in the last quarter. Clearbridge Investments LLC grew its stake in CVS Health by 306.6% in the 4th quarter. Clearbridge Investments LLC now owns 3,046,216 shares of the pharmacy operator’s stock worth $240,529,000 after acquiring an additional 2,297,100 shares in the last quarter. Junto Capital Management LP purchased a new position in shares of CVS Health during the fourth quarter worth approximately $111,209,000. Finally, International Assets Investment Management LLC boosted its holdings in shares of CVS Health by 8,697.2% in the fourth quarter. International Assets Investment Management LLC now owns 1,322,129 shares of the pharmacy operator’s stock valued at $104,395,000 after purchasing an additional 1,307,100 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Mizuho lowered their target price on CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Baird R W raised shares of CVS Health to a “hold” rating in a research report on Thursday, May 30th. JPMorgan Chase & Co. lowered their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a research report on Thursday, May 30th. Wells Fargo & Company cut their price objective on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 7th. Finally, Bank of America lowered their target price on CVS Health from $95.00 to $77.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $75.05.

Insiders Place Their Bets

In other news, Director Edward J. Ludwig acquired 1,000 shares of the company’s stock in a transaction dated Thursday, May 2nd. The shares were acquired at an average price of $53.88 per share, with a total value of $53,880.00. Following the purchase, the director now directly owns 21,630 shares of the company’s stock, valued at $1,165,424.40. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.24% of the stock is owned by insiders.

CVS Health Stock Performance

CVS Health stock traded down $0.82 during trading hours on Thursday, hitting $56.70. 5,371,350 shares of the stock traded hands, compared to its average volume of 10,197,653. CVS Health Co. has a 1 year low of $52.77 and a 1 year high of $83.25. The stock has a market capitalization of $71.18 billion, a price-to-earnings ratio of 9.96, a P/E/G ratio of 0.55 and a beta of 0.52. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.81 and a quick ratio of 0.61. The firm’s 50 day moving average price is $58.89 and its 200-day moving average price is $69.81.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). The business had revenue of $88.44 billion during the quarter, compared to analyst estimates of $89.33 billion. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. CVS Health’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter last year, the company posted $2.20 EPS. As a group, equities analysts expect that CVS Health Co. will post 7.02 EPS for the current fiscal year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.